Successful treatment of a patient with HER2-positive metastatic gastric cancer with third-line combination therapy with irinotecan, 5-fluorouracil, leucovorin and trastuzumab (FOLFIRI-T).
2011
Background: For patients with HER2overexpressing gastric cancer, there is an improved prognosis with additional trastuzumab to chemotherapy with a platinum compound and a fluoropyri
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
16
References
11
Citations
NaN
KQI